Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 5946807, 13 pages
http://dx.doi.org/10.1155/2016/5946807
Review Article

Dendritic Cells and Their Role in Cardiovascular Diseases: A View on Human Studies

1Department of Cardiac Surgery, Heart Center, Helios Clinic, University Hospital Leipzig, 04289 Leipzig, Germany
2Department of Cardiovascular Surgery, University Heart Center Hamburg, 20246 Hamburg, Germany

Received 23 November 2015; Revised 22 January 2016; Accepted 22 February 2016

Academic Editor: Silvia B. Boscardin

Copyright © 2016 Maja-Theresa Dieterlen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Mendis, P. Puska, and B. Norrving, Global Atlas on Cardiovascular Disease Prevention and Control, WHO, Geneva, Switzerland, 2011.
  2. D. A. Chistiakov, I. A. Sobenin, A. N. Orekhov, and Y. V. Bobryshev, “Myeloid dendritic cells: development, functions, and role in atherosclerotic inflammation,” Immunobiology, vol. 220, pp. 833–844, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Dzionek, A. Fuchs, P. Schmidt et al., “BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood,” The Journal of Immunology, vol. 165, no. 11, pp. 6037–6046, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Narbutt, A. Lesiak, M. Zak-Prelich et al., “The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the Polish population,” Cellular and Molecular Biology Letters, vol. 9, no. 3, pp. 497–509, 2004. View at Google Scholar · View at Scopus
  5. H. Yokoyama, S. Kuwao, K. Kohno, K. Suzuki, T. Kameya, and T. Izumi, “Cardiac dendritic cells and acute myocarditis in the human heart,” Japanese Circulation Journal, vol. 64, no. 1, pp. 57–64, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. D. N. J. Hart and J. W. Fabre, “Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissue of rat heart and other tissues, but not brain,” The Journal of Experimental Medicine, vol. 154, no. 2, pp. 347–361, 1981. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Zhang, Z.-X. Yu, S. Fujita, M. L. Yamaguchi, and V. J. Ferrans, “Interstitial dendritic cells of the rat heart. Quantitative and ultrastructural changes in experimental myocardial infarction,” Circulation, vol. 87, no. 3, pp. 909–920, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Banchereau, F. Briere, C. Caux et al., “Immunobiology of dendritic cells,” Annual Review of Immunology, vol. 18, pp. 767–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Sallusto, B. Palermo, D. Lenig et al., “Distinct patterns and kinetics of chemokine production regulate dendritic cell function,” European Journal of Immunology, vol. 29, no. 5, pp. 1617–1625, 1999. View at Google Scholar · View at Scopus
  10. C. Delgado-Martín, C. Escribano, J. L. Pablos, L. Riol-Blanco, and J. L. Rodríguez-Fernández, “Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional akt, Extracellular Signal-regulated Kinase (ERK)1/2, and Mammalian Target of Rapamycin Complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells,” The Journal of Biological Chemistry, vol. 286, no. 43, pp. 37222–37236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. G. J. Randolph, J. Ochando, and S. Partida-Sánchez, “Migration of dendritic cell subsets and their precursors,” Annual Review of Immunology, vol. 26, pp. 293–316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Curtsinger and M. F. Mescher, “Inflammatory cytokines as a third signal for T cell activation,” Current Opinion in Immunology, vol. 22, no. 3, pp. 333–340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Frostegård, “Immunity, atherosclerosis and cardiovascular disease,” BMC Medicine, vol. 11, article 117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Weis, C. L. Schlichting, E. G. Engleman, and J. P. Cooke, “Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1817–1823, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1626–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Frostegård, A.-K. Ulfgren, P. Nyberg et al., “Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines,” Atherosclerosis, vol. 145, no. 1, pp. 33–43, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. L. S. Deluca and J. L. Gommerman, “Fine-tuning of dendritic cell biology by the TNF superfamily,” Nature Reviews Immunology, vol. 12, no. 5, pp. 339–351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. J. Alderman, P. R. Bunyard, B. M. Chain, J. C. Foreman, D. S. Leake, and D. R. Katz, “Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment?” Cardiovascular Research, vol. 55, no. 4, pp. 806–819, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Ge, Q. Jia, C. Liang et al., “Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2157–2163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Aicher, C. Heeschen, M. Mohaupt, J. P. Cooke, A. M. Zeiher, and S. Dimmeler, “Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions,” Circulation, vol. 107, no. 4, pp. 604–611, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Lu, D. Huang, K. Yao et al., “Insulin enhances dendritic cell maturation and scavenger receptor-mediated uptake of oxidised low-density lipoprotein,” Journal of Diabetes and Its Complications, vol. 29, no. 4, pp. 465–471, 2015. View at Publisher · View at Google Scholar
  22. W. Nie, H. Yan, S. Li, W. Zhu, F. Fan, and J. Zhu, “Angiotensin II promotes atherogenesis through upregulating the expression of connexin 43 in dendritic cells,” Cellular and Molecular Biology (Noisy-le-Grand), vol. 61, no. 3, pp. 96–101, 2015. View at Google Scholar
  23. A. Yilmaz, M. Lochno, F. Traeg et al., “Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques,” Atherosclerosis, vol. 176, no. 1, pp. 101–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Niessner, K. Sato, E. L. Chaikof, I. Colmegna, J. J. Goronzy, and C. M. Weyand, “Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-α,” Circulation, vol. 114, no. 23, pp. 2482–2489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Niessner, M. S. Shin, O. Pryshchep, J. J. Goronzy, E. L. Chaikof, and C. M. Weyand, “Synergistic proinflammatory effects of the antiviral cytokine interferon-α and toll-like receptor 4 ligands in the atherosclerotic plaque,” Circulation, vol. 116, no. 18, pp. 2043–2052, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Rohm, Y. Atiskova, S. Drobnik et al., “Decreased regulatory T cells in vulnerable atherosclerotic lesions: imbalance between pro- and anti-inflammatory cells in atherosclerosis,” Mediators of Inflammation, vol. 2015, Article ID 364710, 13 pages, 2015. View at Publisher · View at Google Scholar
  27. E. A. Van Vré, J. M. Bosmans, I. Van Brussel et al., “Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls,” Pathology, vol. 43, no. 3, pp. 239–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Erbel, K. Sato, F. B. Meyer et al., “Functional profile of activated dendritic cells in unstable atherosclerotic plaque,” Basic Research in Cardiology, vol. 102, no. 2, pp. 123–132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Yilmaz, J. Weber, I. Cicha et al., “Decrease in circulating myeloid dendritic cell precursors in coronary artery disease,” Journal of the American College of Cardiology, vol. 48, no. 1, pp. 70–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. E. A. Van Vré, V. Y. Hoymans, H. Bult et al., “Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease,” Coronary Artery Disease, vol. 17, no. 3, pp. 243–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Yilmaz, T. Schaller, I. Cicha et al., “Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease,” Clinical Science, vol. 116, no. 4, pp. 353–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. E. A. Van Vré, I. Van Brussel, K. O. de Beeck et al., “Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function,” Coronary Artery Disease, vol. 21, no. 2, pp. 87–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Van Brussel, E. A. Van Vré, G. R. Y. De Meyer, C. J. Vrints, J. M. Bosmans, and H. Bult, “Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function,” Clinical Science, vol. 120, no. 9, pp. 415–426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Abbas, I. Gregersen, S. Holm et al., “Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis,” Stroke, vol. 46, pp. 793–799, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Cherian, Y. V. Bobryshev, H. Liang et al., “Immunohistochemical and ultrastructural evidence that dendritic cells infiltrate stenotic aortocoronary saphenous vein bypass grafts,” Cardiovascular Surgery, vol. 9, no. 2, pp. 194–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. B. H. Bulkley and G. M. Hutchins, “Accelerated ‘atherosclerosis’. A morphologic study of 97 saphenous vein coronary artery bypass grafts,” Circulation, vol. 55, no. 1, pp. 163–169, 1977. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Campeau, M. Enjalbert, J. Lespérance, C. Vaislic, C. M. Grondin, and M. G. Bourassa, “Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery,” Circulation, vol. 68, no. 3, part 2, pp. II1–II7, 1983. View at Google Scholar
  38. J. Ozmen, Y. V. Bobryshev, and R. S. A. Lord, “CD40 co-stimulatory molecule expression by dendritic cells in primary atherosclerotic lesions in carotid arteries and in stenotic saphenous vein coronary artery grafts,” Cardiovascular Surgery, vol. 9, no. 4, pp. 329–333, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Wick, M. Romen, A. Amberger et al., “Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue,” The FASEB Journal, vol. 11, no. 13, pp. 1199–1207, 1997. View at Google Scholar
  40. P. S. Yusuf, S. Hawken, S. Ôunpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9438, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. D. N. Muller, E. Shagdarsuren, J.-K. Park et al., “Immunosuppressive treatment protects against angiotensin II-induced renal damage,” The American Journal of Pathology, vol. 161, no. 5, pp. 1679–1693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Nataraj, M. I. Oliverio, R. B. Mannon et al., “Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway,” The Journal of Clinical Investigation, vol. 104, no. 12, pp. 1693–1701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. M. S. Madhur, H. E. Lob, L. A. McCann et al., “Interleukin 17 promotes angiotensin II–induced hypertension and vascular dysfunction,” Hypertension, vol. 55, no. 2, pp. 500–507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. D. Crowley, Y.-S. Song, E. E. Lin, R. Griffiths, H.-S. Kim, and P. Ruiz, “Lymphocyte responses exacerbate angiotensin II-dependent hypertension,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 298, no. 4, pp. R1089–R1097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. T. J. Guzik, N. E. Hoch, K. A. Brown et al., “Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction,” Journal of Experimental Medicine, vol. 204, no. 10, pp. 2449–2460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Nguyen, V. L. Chiasson, P. Chatterjee, S. E. Kopriva, K. J. Young, and B. M. Mitchell, “Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension,” Cardiovascular Research, vol. 97, no. 4, pp. 696–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Kirabo, V. Fontana, A. P. C. de Faria et al., “DC isoketal-modified proteins activate T cells and promote hypertension,” The Journal of Clinical Investigation, vol. 124, no. 10, pp. 4642–4656, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Sagar, P. P. Liu, and L. T. Cooper Jr., “Myocarditis,” The Lancet, vol. 379, no. 9817, pp. 738–747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. G. K. Griffin and A. H. Lichtman, “Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis,” Circulation, vol. 127, no. 23, pp. 2257–2260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. R. R. Marty and U. Eriksson, “Dendritic cells and autoimmune heart failure,” International Journal of Cardiology, vol. 112, no. 1, pp. 34–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. N. R. Rose, “Infection, mimics, and autoimmune disease,” The Journal of Clinical Investigation, vol. 107, no. 8, pp. 943–944, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Bachmaier, N. Nikolaus, L. M. de la Maza, P. Sukumar, A. Hessel, and J. M. Penninger, “Chlamydia infections and heart disease linked through antigenic mimicry,” Science, vol. 283, no. 5406, pp. 1335–1339, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. U. Hofmann and S. Frantz, “Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction,” Circulation Research, vol. 116, no. 2, pp. 354–367, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Anzai, T. Anzai, S. Nagai et al., “Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling,” Circulation, vol. 125, no. 10, pp. 1234–1245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Naito, T. Anzai, Y. Sugano et al., “Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction,” Journal of Immunology, vol. 181, no. 8, pp. 5691–5701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. U. Hofmann, N. Beyersdorf, J. Weirather et al., “Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice,” Circulation, vol. 125, no. 13, pp. 1652–1663, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Liu, W. Gao, J. Yuan et al., “Exosomes derived from dendritic cells improve cardiac function via activation of CD4+ T lymphocytes after myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 91, pp. 123–133, 2016. View at Publisher · View at Google Scholar
  58. T. Nagai, S. Honda, Y. Sugano et al., “Decreased myocardial dendritic cells is associated with impaired reparative fibrosis and development of cardiac rupture after myocardial infarction in humans,” Journal of the American Heart Association, vol. 3, Article ID e000839, 2014. View at Publisher · View at Google Scholar
  59. D. Kretzschmar, S. Betge, A. Windisch et al., “Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction,” Clinical Science, vol. 123, no. 6, pp. 387–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Kofler, Z. Sisic, N. Shvets, P. Lohse, and M. Weis, “Expression of circulatory dendritic cells and regulatory T-cells in patients with different subsets of coronary artery disease,” Journal of Cardiovascular Pharmacology, vol. 57, no. 5, pp. 542–549, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Wen, Y. Wen, L. Zhiliang et al., “A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?” Heart and Vessels, vol. 28, no. 2, pp. 135–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Fukunaga, H. Soejima, A. Irie et al., “High ratio of myeloid dendritic cells to plasmacytoid dendritic cells in blood of patients with acute coronary syndrome,” Circulation Journal, vol. 73, no. 10, pp. 1914–1919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Carvalheiro, I. Velada, A. Valado et al., “Phenotypic and functional alterations on inflammatory peripheral blood cells after acute myocardial infarction,” Journal of Cardiovascular Translational Research, vol. 5, no. 3, pp. 309–320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Fukui, H. Yasukawa, Y. Sugi et al., “Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction,” International Journal of Cardiology, vol. 160, no. 3, pp. 216–219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. U. Eriksson, R. Ricci, L. Hunziker et al., “Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity,” Nature Medicine, vol. 9, no. 12, pp. 1484–1490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. A. L. P. Caforio, M. Grazzini, J. M. Mann et al., “Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy,” Circulation, vol. 85, no. 5, pp. 1734–1742, 1992. View at Publisher · View at Google Scholar · View at Scopus
  67. Z. Kaya, C. Leib, and H. A. Katus, “Autoantibodies in heart failure and cardiac dysfunction,” Circulation Research, vol. 110, no. 1, pp. 145–158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Leuschner, J. Li, S. Göser et al., “Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction,” European Heart Journal, vol. 29, no. 16, pp. 1949–1955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Boivin-Jahns, A. Schlipp, S. Hartmann et al., “Antibodies to cardiac receptors,” Herz, vol. 37, no. 8, pp. 843–848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Afanasyeva, D. Georgakopoulos, D. F. Belardi et al., “Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function,” The American Journal of Pathology, vol. 164, no. 3, pp. 807–815, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Pistulli, S. König, S. Drobnik et al., “Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy,” European Journal of Heart Failure, vol. 15, no. 9, pp. 974–985, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Athanassopoulos, L. M. B. Vaessen, A. P. W. M. Maat, A. H. M. M. Balk, W. Weimar, and A. J. J. C. Bogers, “Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses,” European Journal of Cardio-Thoracic Surgery, vol. 25, no. 4, pp. 619–626, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Athanassopoulos, A. H. M. M. Balk, L. M. B. Vaessen et al., “Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy,” International Journal of Cardiology, vol. 131, no. 2, pp. 246–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Sugi, H. Yasukawa, H. Kai et al., “Reduction and activation of circulating dendritic cells in patients with decompensated heart failure,” International Journal of Cardiology, vol. 147, no. 2, pp. 258–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Dieterlen, F. W. Mohr, H. Reichenspurner, and M. J. Barten, “Clinical value of flow cytometric assessment of dendritic cell subsets in peripheral blood after solid organ transplantation,” Cytometry A, vol. 87, no. 5, pp. 377–379, 2015. View at Publisher · View at Google Scholar
  76. P. Athanassopoulos, L. M. B. Vaessen, A. H. M. M. Balk et al., “Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy,” European Journal of Cardio-Thoracic Surgery, vol. 27, no. 5, pp. 783–789, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. P. Athanassopoulos, L. M. B. Vaessen, A. P. W. M. Maat et al., “Preferential depletion of blood myeloid dendritic cells during acute cardiac allograft rejection under controlled immunosuppression,” American Journal of Transplantation, vol. 5, no. 4, pp. 810–820, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. C. S. K. Ho, J. A. López, S. Vuckovic, C. M. Pyke, R. L. Hockey, and D. N. J. Hart, “Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts,” Blood, vol. 98, no. 1, pp. 140–145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. F. S. Dhabhar and B. S. McEwen, “Enhancing versus suppressive effects of stress hormones on skin immune function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 3, pp. 1059–1064, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Monti, P. Allavena, V. Di Carlo, and L. Piemonti, “Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells,” International Immunopharmacology, vol. 3, no. 2, pp. 189–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. T. Luft, M. Jefford, P. Luetjens et al., “Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets,” Blood, vol. 100, no. 4, pp. 1362–1372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. E. Scandella, Y. Men, D. F. Legler et al., “CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2,” Blood, vol. 103, no. 5, pp. 1595–1601, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. G. J. Randolph, “Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators,” Seminars in Immunology, vol. 13, no. 5, pp. 267–274, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Szabo, C. Gavala, and P. Mandrekar, “Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells,” Journal of Investigative Medicine, vol. 49, no. 5, pp. 442–449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. P.-H. Chiang, L. Wang, C. A. Bonham et al., “Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway,” The Journal of Immunology, vol. 172, no. 3, pp. 1355–1363, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. C. Lagaraine and Y. Lebranchu, “Effects of immunosuppressive drugs on dendritic cells and tolerance induction,” Transplantation, vol. 75, no. 9, pp. 37S–42S, 2003. View at Google Scholar · View at Scopus
  87. M. Moser, T. De Smedt, T. Sornasse et al., “Glucocorticoids down-regulate dendritic cell function in vitro and in vivo,” European Journal of Immunology, vol. 25, no. 10, pp. 2818–2824, 1995. View at Publisher · View at Google Scholar · View at Scopus
  88. P. P. C. Boor, H. J. Metselaar, S. Mancham, H. W. Tilanus, J. G. Kusters, and J. Kwekkeboom, “Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells,” American Journal of Transplantation, vol. 6, no. 10, pp. 2332–2341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Shodell and F. P. Siegal, “Corticosteroids depress IFN-α-producing plasmacytoid dendritic cells in human blood,” Journal of Allergy and Clinical Immunology, vol. 108, no. 3, pp. 446–448, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Raimondi and A. W. Thomson, “Dendritic cells, tolerance and therapy of organ allograft rejection,” Contributions to Nephrology, vol. 146, pp. 105–120, 2005. View at Google Scholar · View at Scopus
  91. M. Abe and A. W. Thomson, “Influence of immunosuppressive drugs on dendritic cells,” Transplant Immunology, vol. 11, no. 3-4, pp. 357–365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. K. L. Womer, R. Peng, P. R. Patton et al., “The effects of renal transplantation on peripheral blood dendritic cells,” Clinical Transplantation, vol. 19, no. 5, pp. 659–667, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. V. Daniel, “Dendritic cells and immunosuppression after organ transplantation,” LaboratoriumsMedizin, vol. 32, no. 3, pp. 131–139, 2008. View at Publisher · View at Google Scholar
  94. K. John, M.-T. Dieterlen, A. Tarnok et al., “Role of dendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients,” Cytometry B—Clinical Cytometry, vol. 86, no. 5, pp. 362–367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  95. M. J. Barten, J. Garbade, H. B. Bittner et al., “Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation,” International Immunopharmacology, vol. 6, no. 13-14, pp. 2011–2017, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. C. van Kooten, G. Lombardi, K. A. Gelderman et al., “Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities,” Transplantation, vol. 91, no. 1, pp. 2–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. U. Švajger and P. Rožman, “Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation,” Journal of Leukocyte Biology, vol. 95, no. 1, pp. 53–69, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Moreau, E. Varey, L. Bouchet-Delbos, and M. C. Cuturi, “Cell therapy using tolerogenic dendritic cells in transplantation,” Transplantation Research, vol. 1, no. 1, article 13, 2012. View at Google Scholar
  99. A. Lamioni, F. Parisi, G. Isacchi et al., “The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo,” Transplantation, vol. 79, no. 7, pp. 846–850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. M.-T. Dieterlen, H. B. Bittner, A. Pierzchalski, S. Dhein, F. W. Mohr, and M. J. Barten, “Immunological monitoring of extracorporeal photopheresis after heart transplantation,” Clinical and Experimental Immunology, vol. 176, no. 1, pp. 120–128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Abe, Z. Wang, A. de Creus, and A. W. Thomson, “Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival,” American Journal of Transplantation, vol. 5, no. 8, pp. 1808–1819, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. P. Björck, P. T. H. Coates, Z. Wang, F. J. Duncan, and A. W. Thomson, “Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody,” Journal of Heart and Lung Transplantation, vol. 24, no. 8, pp. 1118–1120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. H. Li and B. Shi, “Tolerogenic dendritic cells and their applications in transplantation,” Cellular and Molecular Immunology, vol. 12, no. 1, pp. 24–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Gregori, D. Tomasoni, V. Pacciani et al., “Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway,” Blood, vol. 116, no. 6, pp. 935–944, 2010. View at Publisher · View at Google Scholar
  105. L. J. Young, N. S. Wilson, P. Schnorrer et al., “Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells,” Nature Immunology, vol. 9, no. 11, pp. 1244–1252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. O. H. Gerstner, W. Laffers, and A. Tárnok, “Clinical applications of slide-based cytometry—an update,” Journal of Biophotonics, vol. 2, no. 8-9, pp. 463–469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. S. M. Cherian, Y. V. Bobryshev, S. J. Inder, A. Y. Wang, R. S. A. Lord, and A. E. Farnsworth, “Dendritic cells in aortocoronary saphenous vein bypass grafts,” Heart Lung and Circulation, vol. 9, no. 1, pp. 39–42, 2000. View at Publisher · View at Google Scholar · View at Scopus